HENDERSON, Nev. – March 25, 2025 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced financial results for the fourth quarter and full-year 2024. “2024 marked another year of outstanding growth and strategic advancement for Paysign,… Read more »
Paysign will be attending the 2025 Asembia Specialty Pharmacy Summit, taking place April 27-May 01, in Las Vegas. The Patient Affordability team will be hosting cocktail style gatherings, as well as one-on-one meetings with interested clients throughout the week. To get in touch or book a meeting with the PA team, email affordability@paysign.com or visit… Read more »
HENDERSON, Nev. – February 27, 2025 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, will discuss fourth quarter and full year 2024 earnings at 5:00 p.m. ET on Tuesday, March 25, 2025. Participant details are as follows:… Read more »
Paysign is excited to be a supporting sponsor at the ACCESS USA event, Accelerating Access, Partnerships and Collaboration to Deliver Superior Patient Outcomes, in Philadelphia, PA on March 18-20, 2025. Our Patient Affordability team will be there, sharing insights on patient access, drug pricing, copay accumulators, and the continued need for transparency within and throughout the… Read more »
Proprietary Feature Demonstrates Advanced Accuracy in Mitigating Copay Maximizers HENDERSON, Nev. – February 4, 2025 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced its annual performance analysis of pharmaceutical copay programs leveraging their patient affordability solutions. Paysign’s dynamic… Read more »
HENDERSON, Nev. – November 5, 2024 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payments processing, today announced financial results for the third quarter 2024. “We are pleased to report strong third-quarter results, achieving 23.0% revenue growth and a… Read more »
Paysign has added to their on-going sponsorship of Informa Connect Life Sciences events with the Patient Support Services Congress, in Philadelphia, PA on November 20-21, 2024. This two-day event will cover critical topics within patient services; uniting compliance and operations teams to positively execute new innovations and strategies in patient services programs.
Paysign will once again sponsor the Plasma Protein Therapeutic Association Forum in Washington, D.C. on November 19-20, 2024. This conference brings together policymakers, industry leaders, healthcare professionals and patients together to learn more about key developments and current issues within the plasma industry.
Paysign is a Sponsor and Participant at the Copay, Reimbursement and Access Congress, Philadelphia, PA Paysign is a sponsor at the upcoming Copay, Reimbursement, and Access Congress, in Philadelphia, PA on November 18-20, 2024. Matt Turner, President of Patient Affordability, will be moderating a panel on the topic of “Ensuring and Executing Innovation Within a… Read more »
HENDERSON, Nev. – October 15, 2024 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, will discuss its third quarter 2024 financial results at 5:00 p.m. Eastern time on Tuesday, November 5, 2024. Participant details are as follows:… Read more »
Want to learn more? Let’s talk about how Paysign can help you achieve your goals.